KEMIFARMA Consulting ApS: Financial statements 2017
CVR: 34709955
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
KEMIFARMA Consulting ApS (CVR 34709955) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -11,388 and a net result of DKK 190,546 compared with DKK 3,802 the year before. Equity in the 2017 report amounted to DKK 2,419,513. The solvency ratio was 99.1%.
- Gross Profit
- DKK -11,388
- Profit/Loss
- DKK 190,546
- Equity
- DKK 2,419,513
- Total Assets
- DKK 2,441,832
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -11K | 191K | 2.4M | - |
| 2016 | - | -13K | 4K | 2.3M | - |
| 2015 | - | -12K | 352K | 2.3M | - |
| 2014 | - | -10K | 296K | 2M | - |
| 2013 | - | -15K | 19K | 1.8M | - |
Official annual report
Keep an eye on KEMIFARMA Consulting ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
KEMIFARMA Consulting ApS has published its annual report for 2016. Gross profit came to DKK -13,413, and the net result was DKK 3,802.
About KEMIFARMA Consulting ApS
KEMIFARMA Consulting ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named KEMIFARMA HOLDING ApS. The management consists of Christian Hede-Andersen. The company is owned by Christian Hede-Andersen. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK -57,469 and a net result of DKK 541,385 compared with DKK -378,700 the year before. Equity in the 2025 report amounted to DKK 3,414,022.